首页> 外文期刊>International Journal of Pharmaceutical Sciences Review and Research >Drug Utilization Study and Adverse Drug Reactions Profile of Drugs in Patients of Ovarian Cancer in Tertiary Care Teaching Hospital
【24h】

Drug Utilization Study and Adverse Drug Reactions Profile of Drugs in Patients of Ovarian Cancer in Tertiary Care Teaching Hospital

机译:三级护理教学医院卵巢癌患者药物利用研究和药物的不良药物反应谱

获取原文
           

摘要

Ovarian cancer is one of the most common gynaecologic cancers.Concerns pertaining to major health burden on society can be reduced by drug utilization study which gives an idea for detecting early signals of irrational drug use This cross-sectional observational study aims at analyzing utilization pattern of drugs and Adverse drug reactions in the treatment of ovarian cancer at a tertiary care hospital in perspective of standard treatment guidelines.170 patients of Ovarian Cancer receiving chemotherapy were enrolled in study after written informed consent of patients.Approval was obtained from institutional ethics committee.It was cross-sectional, observational study.Prescriptions were analysed for number of drugs prescribed using a predesigned format.Any Adverse Drug Reaction (ADR) observed by patient or treating physician was noted and causality was assessed by Naranjo’s algorithm.Preventability and severity of ADRs were assessed by modified Schumock and Thornton scale, modified Hartwig and Siegel scale respectively.In our study, ovarian cancer was encountered maximum in age group of 60-80 years.Most commonly prescribed chemotherapeutic drug was Paclitaxel (96.47%).Causality assessment of ADR by Naranjo’s algorithm showed 45.56% definite, 29.9% probable and 24.54% possible reactions.According to modified Schumock and Thornton scale, 30.73% reactions are ‘not preventable’, 5.36% are probably preventable, 63.91% are ‘definitely preventable’.According to modified Hartwig and Siegel scale, 51.96% were ‘mild’ severity however 48.04% were ‘moderate’ severity.
机译:卵巢癌是最常见的Gynaecologic癌症之一。通过药物利用研究可以减少与社会的主要健康负担有关的核心,这给出了检测不合理药物的早期信号的想法,这种横截面观察研究旨在分析利用模式在标准治疗指南的角度下,在第三节护理医院治疗卵巢癌的药物和不良药物反应.170卵巢癌接受化疗的患者在患者书面知情同意后注册了学习。从制度伦理委员会获得了批准。是横截面的,观察研究。分析了使用预测格式规定的药物数量的预验证。注意到患者或治疗医师观察的不利药物反应(ADR),并通过Naranjo算法评估了因果关系。令人遗症和ADR的严重程度通过改进的舒克和桑顿秤评估,改装哈特SIG和Siegel规模分别。在我们的研究中,卵巢癌在60-80岁的年龄组中遇到了最大的癌症。大多数常见规定的化学治疗药物是紫杉醇(96.47%)。纳兰霍算法的ADR的因果关系评估显示为45.56%的明确,25.56%,29.9%可能和24.54%的可能反应。根据改良的舒克和桑顿标度,30.73%的反应是“不可预防”,5.36%可能是可预防的,63.91%“绝对可以预防”。根据修改的Hartwig和Siegel Scale,51.96%是'温和的严重程度为48.04%是“中等”严重程度。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号